latency-associated degradation mrp1 drug transporter latent human cytomegalovirus infection 
reactivation latent human cytomegalovirus hcmv infection transplantation associated high morbidity mortality vivo myeloid cells progenitors important site hcmv latency whose establishment and/or maintenance require expression viral transcript ul138 using stable isotope labeling amino acids cell culture-based mass spectrometry found dramatic ul138-mediated loss cell surface multidrug resistance-associated protein- mrp1 reduction substrate export transporter latency-associated loss mrp1 accumulation cytotoxic drug vincristine mrp1 substrate depleted virus naturally latent cd14+ cd34+ progenitors vivo sites latency ul138-mediated loss mrp1 provides marker detecting latent hcmv infection therapeutic target eliminating latently infected cells transplantation 
